Skip to content

Influence of Pancreatic Transection With CUSA on Postoperative Pancreatic Fistula Incidence (PANCUT)

Influence of Pancreatic Transection With Cavitron Ultrasonic Surgical Aspirator (CUSA) on Postoperative Pancreatic Fistula Incidence - a Prospective Randomised Controlled Trial: the PANCUT Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06135012
Acronym
PANCUT
Enrollment
160
Registered
2023-11-18
Start date
2023-07-01
Completion date
2025-09-30
Last updated
2023-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic Fistula

Keywords

Pancreatic surgery, Pancreas transection, Postoperative complications, POPF

Brief summary

Objective: To compare the outcomes after elective pancreatic resections using cavitron ultrasonic surgical aspirator (CUSA) and selective closure of small blood vessels and branch pancreatic ducts versus surgical scalpel or stapler for the transection of pancreatic tissue. Study design: A randomized controlled, single centre trial. Study population: Two groups of 80 patients (160 in total) scheduled for elective open pancreaticoduodenectomy (PD) for any indication. Intervention: Transection of pancreatic tissue with CUSA. Control: Standard transection of pancreatic tissue with surgical scalpel (in PD) or stapler (in DP)

Detailed description

Rationale: Postoperative pancreatic fistula (POPF) is one of the major causes of morbidity and mortality after pancreatic resections. There is no predominant surgical technique of pancreatic stump closure in distal pancreatectomy (DP) or formation of pancreaticojejunostomy in pancreaticoduodenectomy (PD) proven to prevent/lower POPF incidence. Cavitron ultrasonic surgical aspirator (CUSA) selectively removes tissue parenchyma, evading blood vessels and pancreatic ducts which could consequently be selectively ligated. Such technique could anull pancreatic juice drainage from branch ducts and provide better (skeletonised) view of the main duct to from an anastomosis (or to ligate it in DP) and thus lower the incidence of POPF formation. Objective: To compare transection of pancreatic tissue with CUSA and selective closure of small blood vessels and branch pancreatic ducts with transection with surgical scalpel or stapler in elective pancreatic resections regarding the incidence of POPF. Study design: A randomized controlled, single centre trial. The study protocol was designed according to the SPIRIT guidelines. Study population: Two groups of 80 patients (160 in total) scheduled for elective open pancreaticoduodenectomy (PD) for any indication. Intervention: Transection of pancreatic tissue with CUSA. Control: Standard transection of pancreatic tissue with surgical scalpel (in PD). Main study parameters/endpoints: Primary outcome is the incidence of POPF. Main secondary outcomes are intraoperative outcomes (such as blood loss and operative time), postoperative outcomes (such as complications, time to functional recovery and hospital stay).

Interventions

DEVICECavitron ultrasonic surgical aspirator (CUSA)

Transection of pancreatic tissue with cavitron ultrasonic surgical aspirator (CUSA).

OTHERScalpel

Transection of pancreatic tissue with scalpel.

Sponsors

University Medical Centre Ljubljana
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients aged 18 years or more * Patients capable of understanding the provided information about the study * Patients with signed informed consent * Planned elective pancreaticoduodenectomy for any indication

Exclusion criteria

* Patients aged less than 18 * Patient incapable of understanding the provided information about the study * Pregnancy * Previous surgical procedures on pancreas * Immunosuppressive therapy * Preoperative radiotherapy

Design outcomes

Primary

MeasureTime frameDescription
Postoperative pancreatic fistula incidence30 daysEvaluation and incidence of postoperative pancreatic fistula

Secondary

MeasureTime frameDescription
Postoperative septic complications90 daysIntraabdominal collections, antibiotic treatment
Number of postoperative interventions90 daysPercutaneous drain placement or reoperations
Hospital stay90 daysDays in hospital
Volume of intraoperative blood loss1 dayBlood loss during surgery
Operative time1 dayTime spent for pancreas transection

Countries

Slovenia

Contacts

Primary ContactDavid Badovinac
david.badovinac@kclj.si+38615224788
Backup ContactBenjamin Hadžialjević
benjamin.hadzialjevic@kclj.si+38615224788

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026